Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient.
Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient.
复制标题
实体瘤的快速蛋白质组学分析揭示了LSD1是末期癌症患者的药物靶标。
DOI:
10.1002/1878-0261.12326
复制
发表时间:
2018-08
影响因子:
6.6
通讯作者:
Mann M
中科院分区:
文献类型:
--
作者:
Doll S;Kriegmair MC;Santos A;Wierer M;Coscia F;Neil HM;Porubsky S;Geyer PE;Mund A;Nuhn P;Mann M
Recent advances in mass spectrometry (MS)‐based technologies are now set to transform translational cancer proteomics from an idea to a practice. Here, we present a robust proteomic workflow for the analysis of clinically relevant human cancer tissues that allows quantitation of thousands of tumor proteins in several hours of measuring time and a total turnaround of a few days. We applied it to a chemorefractory metastatic case of the extremely rare urachal carcinoma. Quantitative comparison of lung metastases and surrounding tissue revealed several significantly upregulated proteins, among them lysine‐specific histone demethylase 1 (LSD1/KDM1A). LSD1 is an epigenetic regulator and the target of active development efforts in oncology. Thus, clinical cancer proteomics can rapidly and efficiently identify actionable therapeutic options. While currently described for a single case study, we envision that it can be applied broadly to other patients in a similar condition.
登录
查看更多内容
影响因子:
7
作者:
Kabuyama, Yukihito;Litman, Elizabeth S.;Ahn, Natalie G.
通讯作者:
Ahn, Natalie G.
影响因子:
15.9
作者:
Mikheev, Andrei M.;Mikheeva, Svetlana A.;Rostomily, Robert C.
通讯作者:
Rostomily, Robert C.
影响因子:
1.9
作者:
Lin, Xiandong;Hu, Don;Luo, Xingguang
通讯作者:
Luo, Xingguang
影响因子:
30.8
作者:
通讯作者:
--
影响因子:
4.1
作者:
Bornstein, Paul
通讯作者:
Bornstein, Paul